TXMD compared with OPK: revenue, margins and what each company keeps, and the suppliers and customers both name

TXMDTherapeuticsMD, Inc.

Mkt capRevenueRevenue

OPKOpko Health, Inc.

Mkt capRevenueRevenue

Compare

TXMDTherapeuticsMD, Inc.

OPKOpko Health, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TXMD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.3%▲+0.48%×0.03

OPK

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±30.0%▼−1.13%×0.04

Q2 FY26±21.7%▲+33.06%×1.53

= impliedTXMD realized, solidOPK realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

Q1 FY26

±22.6%

▼−8.26%

×0.37

Feb 27 '26±23.8%0.00%×0.00

TXMDTherapeuticsMD, Inc.

1.66▼−2.92%· post 1.66

Mkt cap$20.3MRevenue$869,000Q2 FY26Revenue$3MFY25

OPKOpko Health, Inc.

1.74▼−0.50%· post 1.74

ClosedNov 6 '26

Mkt cap$1.3BRevenue$65MQ3 FY26Revenue$607MFY25

Compare

ClosedNov 6 '26

TXMDTherapeuticsMD, Inc.

OPKOpko Health, Inc.

1.66▼−2.92%post 1.66

Price

1.74▼−0.50%post 1.74

$20.3M

Mkt cap

$1.3B

Q2 FY26$869,000

Revenue

$65MQ3 FY26

FY25$3M

Revenue

$607MFY25

TXMD1.66▼−2.92%vsOPK1.74▼−0.50%ClosedNov 6 '26